Gujarat Themis Biosyn

Manufacturing · India · 51-200 Employees

View Company Info for Free

Overview

Headquarters

69/c Gidc Industrial Est, Vapi, Gujarat,...

Phone Number

+91 2267607080

Revenue

$14.3 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Gujarat Themis Biosyn

Gujarat Themis Biosyn Limited specializes in the manufacture of bulk drugs, with a notable history as India's first company to commercially produce the anti-tuberculosis drug Rifampicin. Established in 1981, it operates under a joint venture that includes several prominent pharmaceutical companies. The company is actively managed by Themis Medicare Ltd. since 2007 and serves clients in the pharmaceutical sector. Its commitment to research and development underpins its innovative approach to drug manufacturing.Explore more
Gujarat Themis Biosyn's Social MediaPopular SearchesGujarat Themis Biosyn LtdGujarat ThemisSIC Code 28,283NAICS Code 32,325Show more

Gujarat Themis Biosyn Org Chart

PhoneEmail
SP
India flag for contact location.

General Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
HW
India flag for contact location.

Senior Manager, Environmental Health & Safety

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Gujarat Themis Biosyn your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Gujarat Themis Biosyn is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Gujarat Themis Biosyn is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gujarat Themis Biosyn.

Gujarat Themis Biosyn Tech Stack

A closer look at the technologies used by Gujarat Themis Biosyn

Most Recent Scoops

Project
Gujarat Themis Biosyn has expanded its gross block from approximately INR 62 crore in FY23 to approximately INR 435 crore including capital work-in-progress in FY26, representing an incremental investment of approximately INR 370 crore over three years across its new fermentation facility, API facilities, R&D infrastructure, and hybrid power project, with the fermentation and API facility assets expected to generate an asset turn of 1.4 to 1.5 times.
Spending/Investment, Research & Development
Pain Point
Gujarat Themis Biosyn has announced that a commercial dispute with Optimus Drugs has been resolved and that business between the two companies is resuming, with Gujarat Themis Biosyn noting that it was able to sell its full production capacity through alternative buyers during the period in which supply to Optimus Drugs was suspended.
Contracts
Partnership
Gujarat Themis Biosyn has entered into a three-year transition service agreement with Sanofi, under which marketing authorizations for the acquired brand portfolio will be transferred country by country from Sanofi to Gujarat Themis Biosyn, with all technology transfers expected to be completed within the first year and full manufacturing control targeted well ahead of the three-year term.
Partnership
Project
Gujarat Themis Biosyn has announced that its multi-phase capital expenditure program is substantially complete, with approximately INR 20 crore in remaining spend expected for FY27, covering last-mile items and maintenance capital expenditure.
Spending/Investment, Business Finance, Finance
Earnings
Earnings, Finance
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding Gujarat Themis Biosyn

What is Gujarat Themis Biosyn's official website?
Gujarat Themis Biosyn's official website is www.gtbl.in
What is Gujarat Themis Biosyn's Revenue?
Gujarat Themis Biosyn's revenue is $14.3 Million
What is Gujarat Themis Biosyn's SIC code?
Gujarat Themis Biosyn's SIC: 28,283
What is Gujarat Themis Biosyn's NAICS code?
Gujarat Themis Biosyn's NAICS: 32,325
How many employees does Gujarat Themis Biosyn have?
Gujarat Themis Biosyn has 51-200 employees
What industry does Gujarat Themis Biosyn belong to?
Gujarat Themis Biosyn is in the industry of: Manufacturing, Pharmaceuticals
What technology does Gujarat Themis Biosyn use?
Some of the popular technologies that Gujarat Themis Biosyn uses are: WordPress.org, PHP, Google Website Translator, Google Universal Analytics
How do I contact Gujarat Themis Biosyn?
Gujarat Themis Biosyn contact info: Phone number: +91 2267607080 Website: www.gtbl.in
What does Gujarat Themis Biosyn do?

Gujarat Themis Biosyn Limited specializes in the manufacture of bulk drugs, with a notable history as India's first company to commercially produce the anti-tuberculosis drug Rifampicin. Established in 1981, it operates under a joint venture that includes several prominent pharmaceutical companies. The company is actively managed by Themis Medicare... Ltd. since 2007 and serves clients in the pharmaceutical sector. Its commitment to research and development underpins its innovative approach to drug manufacturing.Read More

What are Gujarat Themis Biosyn social media links?
Gujarat Themis Biosyn Linkedin page
Is Gujarat Themis Biosyn a public company?
Gujarat Themis Biosyn is private company therefore does not currently have an official ticker symbol
See more information about Gujarat Themis Biosyn

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.